NR4A2 and Parkinson disease: In the transcriptomics meta-analysis presented here, NR4A2 generally displays lower expression in PD patients than in matched controls, but the expression change is significantly more pronounced in males than in females (females: LFC = −0.6, FDR = 1; males: LFC = −1.4, FDR = 1.6e−8).